loading
前日終値:
$178.08
開ける:
$180.5
24時間の取引高:
144.47K
Relative Volume:
0.22
時価総額:
$9.72B
収益:
$4.06B
当期純損益:
$413.08M
株価収益率:
22.18
EPS:
8.01
ネットキャッシュフロー:
$560.48M
1週間 パフォーマンス:
-6.02%
1か月 パフォーマンス:
-7.28%
6か月 パフォーマンス:
-18.33%
1年 パフォーマンス:
-16.50%
1日の値動き範囲:
Value
$175.76
$182.25
1週間の範囲:
Value
$175.61
$190.68
52週間の値動き範囲:
Value
$175.61
$275.00

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1191)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
0
Name
Twitter
@criverlabs
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

CRL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
CRL
Charles River Laboratories International Inc
177.51 9.72B 4.06B 413.08M 560.48M 8.01
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
560.87 213.05B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
240.78 171.63B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
145.25 40.96B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
198.91 35.93B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
429.09 34.28B 3.84B 866.24M 792.60M 10.37

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
07:59 AM

Charles River Labs stock target cut, hold rating on expected decline - Investing.com

07:59 AM
pulisher
05:10 AM

Charles River Laboratories International (NYSE:CRL) Reaches New 1-Year LowHere's Why - MarketBeat

05:10 AM
pulisher
Jan 14, 2025

Citi flags revenue and margin headwinds for Charles River Labs shares By Investing.com - Investing.com South Africa

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Seeks Strategic Acquisitions - Marketscreener.com

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Laboratories International's (CRL) "Outperform" Rating Reiterated at William Blair - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

BofA keeps Charles River Labs stock at Neutral on challenges By Investing.com - Investing.com Canada

Jan 14, 2025
pulisher
Jan 14, 2025

TD Cowen cautious on Charles River Labs stock as 2025 guide signals further declines - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

JPMorgan maintains Charles River Labs stock at Neutral on challenges - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Citi flags revenue and margin headwinds for Charles River Labs shares - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Laboratories International (NYSE:CRL) Shares Gap DownWhat's Next? - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Labs stock hits 52-week low at $176.34 By Investing.com - Investing.com Canada

Jan 14, 2025
pulisher
Jan 14, 2025

JPMorgan maintains Charles River Labs stock at Neutral on challenges By Investing.com - Investing.com Nigeria

Jan 14, 2025
pulisher
Jan 14, 2025

Clinical Trials Support Services Market Poised for Notable Expansion by 2030, Driven by Substantial Investments in R&D from Pharmaceutical and Biopharmaceutical Companies - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Laboratories (CRL) Provides Preliminary 2025 Finan - GuruFocus.com

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River falls after projecting 2025 revenue drop - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Labs stock hits 52-week low at $176.34 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River stock falls on 2025 revenue drop (CRL:NYSE) - Seeking Alpha

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Labs Discusses 2025 Financial Outlook - TipRanks

Jan 14, 2025
pulisher
Jan 14, 2025

Charles River Laboratories stock falls on weak 2025 revenue outlook By Investing.com - Investing.com UK

Jan 14, 2025
pulisher
Jan 14, 2025

Bioanalytical Testing Services Market Size, Embracing Growth - openPR

Jan 14, 2025
pulisher
Jan 13, 2025

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 13, 2025
pulisher
Jan 13, 2025

Reinhart Partners LLC. Sells 11,822 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Jan 13, 2025
pulisher
Jan 13, 2025

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference - sharewise

Jan 13, 2025
pulisher
Jan 13, 2025

Charles River Labs to Present Strategic Overview at J.P. Morgan Healthcare Conference - StockTitan

Jan 13, 2025
pulisher
Jan 13, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat

Jan 13, 2025
pulisher
Jan 11, 2025

First Hawaiian Bank Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Charles River Laboratories International Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jan 10, 2025
pulisher
Jan 10, 2025

What Charles River Laboratories International, Inc.'s (NYSE:CRL) P/E Is Not Telling You - Simply Wall St

Jan 10, 2025
pulisher
Jan 07, 2025

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Deciphex Secures $32.3M Series C to Transform AI-Powered Pathology Diagnosis - StockTitan

Jan 07, 2025
pulisher
Jan 03, 2025

Preclinical Medical Device Testing Services Market Outlook, - GlobeNewswire

Jan 03, 2025
pulisher
Jan 03, 2025

Preclinical Medical Device Testing Services Market Outlook, 2025-2035Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services - Yahoo Finance

Jan 03, 2025
pulisher
Jan 03, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Jan 03, 2025
pulisher
Jan 02, 2025

Should You Retain Charles River Stock in Your Portfolio Now? - MSN

Jan 02, 2025
pulisher
Dec 31, 2024

CHARLES RIVER LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag - AccessWire

Dec 31, 2024
pulisher
Dec 30, 2024

Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? - MSN

Dec 30, 2024
pulisher
Dec 30, 2024

Charles River Laboratories Stock: Is CRL Underperforming The Healthcare Sector? - Barchart

Dec 30, 2024
pulisher
Dec 27, 2024

Zacks Research Issues Negative Forecast for CRL Earnings - MarketBeat

Dec 27, 2024
pulisher
Dec 26, 2024

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Dec 26, 2024
pulisher
Dec 26, 2024

Declining Stock and Solid Fundamentals: Is The Market Wrong About Charles River Laboratories International, Inc. (NYSE:CRL)? - Simply Wall St

Dec 26, 2024
pulisher
Dec 25, 2024

RNA Therapy Clinical Trials Market Top Companies StudyIQVIA; - openPR

Dec 25, 2024
pulisher
Dec 24, 2024

Charles River Laboratories International Inc. stock rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024
pulisher
Dec 19, 2024

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Dec 19, 2024
pulisher
Dec 19, 2024

Interesting CRL Put And Call Options For August 2025 - Nasdaq

Dec 19, 2024
pulisher
Dec 19, 2024

Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects - Yahoo Finance

Dec 19, 2024
pulisher
Dec 19, 2024

Charles River Laboratories International, Inc. (NYSE:CRL) Receives $214.00 Average Price Target from Brokerages - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR

Dec 19, 2024
pulisher
Dec 17, 2024

Sanctuary Advisors LLC Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Dec 17, 2024

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research LH
$237.20
price up icon 0.97%
$172.57
price up icon 4.12%
$139.32
price up icon 2.47%
diagnostics_research WAT
$409.32
price up icon 1.07%
diagnostics_research MTD
$1,306.00
price up icon 2.60%
$428.76
price up icon 2.42%
大文字化:     |  ボリューム (24 時間):